Validation of prostate‐specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries-Reference-Cited by-同舟云学术

Validation of prostate‐specific antigen laboratory values recorded in Surveillance, Epidemiology, and End Results registries

Published:2016-10-26 Issue:4 Volume:123 Page:697-703
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

,Adamo Margaret (Peggy)¹,Boten Jessica A.¹,Coyle Linda M.²,Cronin Kathleen A.¹,Lam Clara J. K.¹,Negoita Serban³,Penberthy Lynne¹,Stevens Jennifer L.²,Ward Kevin C.⁴

Affiliation:

1. Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer InstituteBethesda Maryland

2. Information Management Services IncCalverton Maryland

3. Westat IncRockville Maryland

4. Department of Epidemiology, Rollins School of Public HealthEmory UniversityAtlanta Georgia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.30401

Reference23 articles.

1. Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement

2. Prostate Cancer Screening: What We Know, Don't Know, and Believe

3. What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation

4. Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer.

5. Results of Conservative Management of Clinically Localized Prostate Cancer

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural Product-Based Studies for the Management of Castration-Resistant Prostate Cancer: Computational to Clinical Studies;Frontiers in Pharmacology;2021-10-19

2. Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications;Prostate International;2021-06

3. Prognostic Models for Patients With Gleason Score 9 Prostate Cancer: A Population-Based Study;Frontiers in Oncology;2021-04-26

4. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database;The Lancet Digital Health;2021-03

5. Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups;European Urology Oncology;2020-10